(Q46665624)

24 December 2017

title

Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism (English)

1 reference

24 December 2017

1 reference

1

Takashi Akiba

1 reference

24 December 2017

Tadao Akizawa

2

object named as

Tadao Akizawa

1 reference

24 December 2017

author name string

Yusuke Tsukamoto

3

1 reference

24 December 2017

Eiji Uchida

4

1 reference

24 December 2017

Manabu Iwasaki

5

1 reference

24 December 2017

Shozo Koshikawa

6

1 reference

24 December 2017

KRN1493 Study Group

7

1 reference

24 December 2017

publication date

1 April 2008

1 reference

24 December 2017

Therapeutic Apheresis and Dialysis

published in

1 reference

24 December 2017

volume

12

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

117-125

1 reference

24 December 2017

Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

Recent developments in the management of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

Clinical experience with cinacalcet HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2008.00556.X

10.1111/J.1744-9987.2008.00556.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017